LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

COMORBIDITIES IN PULMONARY ARTERIAL HYPERTENSION (PAH): INSIGHTS FROM THE REAL-WORLD OPSUMIT® USERS (OPUS) REGISTRY

Photo by nci from unsplash

Many patients with PAH have comorbidities that may exclude them from clinical trials due to stringent inclusion criteria. The OPUS Registry ([NCT02126943][1]) is an ongoing, prospective, multicenter, US drug registry… Click to show full abstract

Many patients with PAH have comorbidities that may exclude them from clinical trials due to stringent inclusion criteria. The OPUS Registry ([NCT02126943][1]) is an ongoing, prospective, multicenter, US drug registry of patients newly treated with macitentan. Here, patient and disease

Keywords: comorbidities pulmonary; arterial hypertension; opus registry; hypertension pah; pulmonary arterial; registry

Journal Title: Journal of the American College of Cardiology
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.